Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
2018 · Scientific Reports · 218 citations
https://doi.org/10.1038/s41598-018-24437-5
N
Nataliya Rohr‐Udilova
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
1.6K
Citations
19
h-index
29
i10-index
Nataliya Rohr‐Udilova is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Lanthanide and Transition Metal Complexes. The author has an h-index of 19, co-authored 67 publications.
ORCID: 0000-0003-2432-3632Papers by this author
worksAnalysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response
2019 · Gastroenterology · 173 citations
https://doi.org/10.1053/j.gastro.2019.05.001
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study
2011 · Alimentary Pharmacology & Therapeutics · 96 citations
https://doi.org/10.1111/j.1365-2036.2011.04896.x
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats
2018 · Scientific Reports · 52 citations
https://doi.org/10.1038/s41598-018-27656-y
A fingerprint of 2-[18F]FDG radiometabolites – How tissue-specific metabolism beyond 2-[18F]FDG-6-P could affect tracer accumulation
2023 · iScience · 5 citations
https://doi.org/10.1016/j.isci.2023.108137
Supplementary Material for: Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.6634190
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat